Compare Norfolk Southern Corporation (NSC) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Norfolk Southern Corporation vs Regeneron Pharmaceuticals Inc — how do they compare? Norfolk Southern Corporation trades at $333.48 (market cap $75.23B), while Regeneron Pharmaceuticals Inc trades at $680.5 (market cap $70.47B). The key difference: Norfolk Southern Corporation and Regeneron Pharmaceuticals Inc are close in size by market cap, and Norfolk Southern Corporation pays the higher dividend (1.61%). Which is the better fit depends on your goals.
| NSC | REGN | |
|---|---|---|
Market Cap | $75.23B | $70.47B |
Sector | Technology | Health |
52-Week High | $340.16 | $812.27 |
52-Week Low | $272.35 | $545.46 |
Enterprise Value | $90.99B | $64.42B |
Dividend Yield | 1.61% | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Norfolk Southern Corporation
Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.
Read more on NSC →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
